Protein & Cell >

2016 , Vol. 7 >Issue 4: 295 - 299

DOI: https://doi.org/10.1007/s13238-016-0251-z

LETTER

Overexpression of SIRT3 disrupts mitochondrial proteostasis and cell cycle progression

  • Xiaofei Wang 1 ,
  • Haiping Tang 1 ,
  • Yuling Chen 1 ,
  • Binghuan Chi 2 ,
  • Shiyu Wang 3 ,
  • Yang Lv 3 ,
  • Di Wu 3 ,
  • Renshan Ge 2 ,
  • Haiteng Deng , 1
Expand
  • 1. MOE Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing 100084, China
  • 2. Wenzhou Medical College, Wenzhou 325035, China
  • 3. Center of Nephrology, The General Hospital of the PLA, Beijing 100853, China

Published date: 09 May 2016

Copyright

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Fold

Cite this article

Xiaofei Wang , Haiping Tang , Yuling Chen , Binghuan Chi , Shiyu Wang , Yang Lv , Di Wu , Renshan Ge , Haiteng Deng . Overexpression of SIRT3 disrupts mitochondrial proteostasis and cell cycle progression[J]. Protein & Cell, 2016 , 7(4) : 295 -299 . DOI: 10.1007/s13238-016-0251-z

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Alhazzazi TY, Kamarajan P, Verdin E, Kapila YL (2011) SIRT3 and cancer: tumor promoter or suppressor? Biochim Biophys Acta 1816:80–88

2
Ashraf N, Zino S, Macintyre A, Kingsmore D, Payne AP, George WD, Shiels PG (2006) Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer 95:1056–1061

DOI

3
Carracedo A, Cantley LC, Pandolfi PP (2013) Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 13:227–232

DOI

4
Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353:2477–2490

DOI

5
Debeb BG, Zhang X, Krishnamurthy S, Gao H, Cohen E, Li L, Rodriguez AA, Landis MD, Lucci A, Ueno NT (2010) Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Mol Cancer 9:180

DOI

6
Finley LW, Haigis MC (2012) Metabolic regulation by SIRT3: implications for tumorigenesis. Trends Mol Med 18:516–523

DOI

7
Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM (2010) SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17:41–52

DOI

8
McDonnell E, Peterson BS, Bomze HM, Hirschey MD (2015) SIRT3 regulates progression and development of diseases of aging. Trends Endocrinol Metab 26:486–492

DOI

9
Papa L, Germain D (2014) SirT3 regulates the mitochondrial unfolded protein response. Mol Cell Biol 34:699–710

DOI

10
Qiu X, Brown K, Hirschey MD, Verdin E, Chen D (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12:662–667

DOI

11
Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501–1512

DOI

12
Verdin E, Hirschey MD, Finley LW, Haigis MC (2010) Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 35:669–675

DOI

13
Yang Y, Chen KY, Tong Q (2011) Murine Sirt3 protein isoforms have variable half-lives. Gene 488:46–51

DOI

14
Yu W, Dittenhafer-Reed KE, Denu JM (2012) SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J Biol Chem 287:14078–14086

DOI

Options
Outlines

/

〈 〉